Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders - Related Studies

Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

This study is ongoing, but not recruiting participants.

Study NCT00006056. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Chediak-Higashi Syndrome
		Graft Versus Host Disease
		Hemophagocytic Lymphohistiocytosis

2	Additional conditions recognized in this trial
		Graft vs Host Disease
		Lymphohistiocytosis, Hemophagocytic
		Lymphoproliferative Disorders
		Syndrome

3	More general conditions related to this trial
		Disease
		Hematologic Diseases
		Histiocytosis
		Histiocytosis, Non-Langerhans-Cell
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Immunoproliferative Disorders
		Leukocyte Disorders
		Lymphatic Diseases
		Pathologic Processes
		Phagocyte Bactericidal Dysfunction
		Reticuloendotheliosis

4	Interventions listed in this trial
		anti-thymocyte globulin
		busulfan
		cyclophosphamide
		cyclosporine
		etoposide
		filgrastim
		methotrexate

5	Additional drug interventions recognized in this trial
		Antilymphocyte Serum
		Cyclosporins

6	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Alkylating Agents
		Anti-Infective Agents
		Antifungal Agents
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Fairview University Medical Center